-
61
Willingness to pay for vaccines in China: A systematic review and single-arm Bayesian meta-analysis
Published 2025-12-01“…Human Vaccines & Immunotherapeutics…”
Get full text
Article -
62
Efficiency enhancement in main path extraction in mRNA vaccine field: A novel approach leveraging intermediate patents, with shielding origin and terminus patent edges
Published 2025-12-01“…Human Vaccines & Immunotherapeutics…”
Get full text
Article -
63
Profile of Chlamydia vaccine research: A bibliometric analysis
Published 2025-12-01“…Human Vaccines & Immunotherapeutics…”
Get full text
Article -
64
“The big topic is COVID”: A qualitative study about changes in HPV vaccine conversations between parents and primary care team members throughout the COVID-19 pandemic
Published 2025-12-01“…Human Vaccines & Immunotherapeutics…”
Get full text
Article -
65
Development and Validation of an Immunotherapy-Related Prognostic Signature Based on Lymph Node Ratio for Gastric Cancer
Published 2023-01-01“…We then evaluated the risk score signature from the viewpoints of survival, clinic-pathological characteristics, tumor microenvironment (TME), tumor mutation burden (TMB), and immunotherapeutic and chemotherapeutic efficacy. Results. …”
Get full text
Article -
66
Exosome-Associated Gene Signature for Predicting the Prognosis of Ovarian Cancer Patients
Published 2023-01-01“…We also assessed the function of the ERGRS to forecast immunotherapeutic efficacy by immunophenoscore (IPS). Results. …”
Get full text
Article -
67
NEIL3 Mediates Lung Cancer Progression and Modulates PI3K/AKT/mTOR Signaling: A Potential Therapeutic Target
Published 2022-01-01“…The predicted result of TIDE indicated that immunotherapeutic nonresponders had elevated NEIL3 levels. …”
Get full text
Article -
68
Sp17 Protein Expression and Major Histocompatibility Class I and II Epitope Presentation in Diffuse Large B Cell Lymphoma Patients
Published 2017-01-01“…This is the first report of a CTL and a CD4 Th response to Sp17 in DLBCL and supports Sp17 as a potential immunotherapeutic target for DLBCL.…”
Get full text
Article -
69
A Severe Case of Ipilimumab-Induced Ileocolitis Refractory to Glucocorticosteroids and Infliximab
Published 2018-01-01“…Ipilimumab is a monoclonal antibody that works as an immunotherapeutic agent through selective targeting of T cells to strengthen the response to metastatic melanoma. …”
Get full text
Article -
70
Predicting immunotherapy efficacy in endometrial cancer: focus on the tumor microenvironment
Published 2025-01-01“…The identification of predictive biomarkers for immunotherapeutic response and the innovative agents capable of reversing resistance pathways must be developed. …”
Get full text
Article -
71
Investigation of Scutellaria Barbata’s immunological mechanism against thyroid cancer using network pharmacology and experimental validation
Published 2025-01-01“…The expression, prognosis, and immunotherapeutic roles of core genes were validated using TCGA databases. …”
Get full text
Article -
72
Reprogramming the tumor immune microenvironment using engineered dual-drug loaded Salmonella
Published 2024-08-01“…Abstract Synergistic combinations of immunotherapeutic agents can improve the performance of anti-cancer therapies but may lead to immune-mediated adverse effects. …”
Get full text
Article -
73
Comprehensive single-cell pan-cancer atlas unveils IFI30+ macrophages as key modulators of intra-tumoral immune dynamics
Published 2025-01-01“…IFI30 emerges as a prospective intervention point in the immunotherapeutic landscape.…”
Get full text
Article -
74
Clinical Diagnosis of an Autoimmune Encephalitis Presented as a Manic Episode with Psychotic Symptoms: A Case Report
Published 2022-01-01“…In places where there is no antibody measurement, or when its measurement is negative, the clinical suspicion supported by CSF studies, magnetic resonance imaging, and electroencephalographic recording, should guide us to start immunotherapeutic treatment early. The early initiation of treatment ensures the reversibility of the neurological disorder in the vast majority of patients.…”
Get full text
Article -
75
Heterogeneity of cancer-associated fibroblast subpopulations in prostate cancer: Implications for prognosis and immunotherapy
Published 2025-02-01“…Conclusion: This investigation illuminates the critical potential of targeting CAFs to augment immunotherapeutic approaches in prostate cancer. Our findings contribute to a deeper understanding of the TME's complexity, advocating for further exploration into CAF-targeted therapies aimed at enhancing treatment responses and ultimately improving patient outcomes.…”
Get full text
Article -
76
A reasonable Approach for the Treatment of HIV Infection in the Early Phase with Ozonetherapy (Autohaemotherapy). How ‘Inflammatory’ Cytokines may have A therapeutic Role
Published 1994-01-01“…In the last 7 years we have clarified the main mechanisms of action of an unorthodox immunotherapeutic method first used 40 years ago. Optimized autohaemotherapy after a brief exposure ofblood to ozone may today afford the trick of reprogramming the immune system to keep HIV at bay. …”
Get full text
Article -
77
Lessons from Cancer Immunoediting in Cutaneous Melanoma
Published 2012-01-01“…We will describe the different immunotherapeutic strategies employed and consider current models accounting for tumor heterogeneity. …”
Get full text
Article -
78
Melanoma-Targeted Chemothermotherapy and In Situ Peptide Immunotherapy through HSP Production by Using Melanogenesis Substrate, NPrCAP, and Magnetite Nanoparticles
Published 2013-01-01“…Magnetite nanoparticles were conjugated with NPrCAP to introduce thermotherapeutic and immunotherapeutic effects through nonapoptotic cell death and generation of heat shock protein (HSP) upon exposure to alternating magnetic field (AMF). …”
Get full text
Article -
79
A Review on the Application of PD-1 Blockade in EBV-Associated Nasopharyngeal Carcinoma Immunotherapy
Published 2022-01-01“…Herein, we have extensively addressed the role of the PD-1/PD-L1 axis in the immunotherapy of EBV-associated NPC. Immunotherapeutic strategies are anticipated to enter mainstream clinical practise and provide long-term remissions in patients with severe NPC.…”
Get full text
Article -
80
Invariant NKT Cells as Novel Targets for Immunotherapy in Solid Tumors
Published 2012-01-01“…Increased understanding of the signals that determine the function of NKT cells in cancer will be essential to improve current strategies for NKT-cell-based immunotherapeutic approaches.…”
Get full text
Article